Business Context and Reporting Period
This Form 8-K Current Report was filed by AngioDynamics, Inc. on August 15, 2006. The filing details actions taken by the Compensation Committee of the Board of Directors regarding executive and director compensation, including salary adjustments, bonus program amendments, and stock option grants.
Key Financial Metrics
The filing does not report company-wide revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on compensation figures for specific individuals:
- Director Compensation: Annual cash retainer for committee chairmen increased to $5,000, effective retroactively to June 6, 2006.
- Fiscal 2007 Base Salaries:
- Eamonn P. Hobbs (CEO/President): $313,000
- Paul J. Shea (VP, Sales): $185,427
- Robert M. Rossell (VP, Marketing): $185,317
- Brian S. Kunst (VP, Regulatory Affairs): $173,500
- William M. Appling (VP, Research): $176,578
- Fiscal 2006 Bonus Payments: Total bonuses paid to named executive officers ranged from approximately $22,950 to $57,101 per individual, comprising MBO bonuses and EBIT/overachievement bonuses.
Material Changes Versus Prior Period
- CEO Bonus Target: The target bonus for the CEO under the Management Profitability Bonus Program was increased from 40% to 50% of base salary for fiscal 2007 and subsequent years.
- Director Retainers: New annual cash retainers of $5,000 were established for the chairmen of the Compensation and Nominating & Corporate Governance Committees.
- Executive Salaries: Base salaries for the CEO and other named executive officers were increased for fiscal 2007.
Guidance, Outlook, and Management Commentary
The filing does not provide financial guidance, revenue outlook, or general management commentary on market conditions. However, it outlines the structure of the Management Profitability Bonus Program:
- Bonus Structure: 30% of the target bonus is payable at fiscal year-end contingent on individual Management by Objectives (MBOs). The remaining 70% is paid quarterly based on company EBIT budget objectives, with 25% of each quarterly payment held in escrow pending achievement of the annual EBIT goal.
- Performance Metrics: CEO MBOs for fiscal 2007 include financial benchmarks such as revenues, gross margins, EBIT, and expense limitations, alongside personal performance objectives.
- Stock Options: Non-qualified stock options were granted to executive officers under the 2004 Stock and Incentive Award Plan, reported separately on Form 4 filings.
Important Facts for Investor Verification
- Verify the impact of the increased CEO bonus target (50% of salary) on future compensation expenses.
- Confirm the specific EBIT budget objectives required to release the escrowed portion of executive bonuses.
- Review the Form 4 filings referenced in the text for details on the number and terms of stock options granted to executives.
- Note that the filing contains no data on the company's overall financial performance (revenue, net income, or cash flow) for the period.